Anixa Biosciences (NASDAQ:ANIX) Given Buy Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $12.00 target price on the stock. Separately, TheStreet lowered Anixa Biosciences from a c- rating to a d rating in a research note on Friday, June 16th. […]

Related Keywords

Anixa Biosciences ,Amit Kumar ,International Assets Investment Management ,Anixa Biosciences Inc ,Us Bancorp ,Virtu Financial ,Westside Investment Management Inc ,Nations Financial Group Inc ,Free Report ,Get Free Report ,Financial Group ,Investment Management ,Assets Investment Management ,Anixa Biosciences Daily ,Nasdaq Anix ,Sanix ,Medical ,Reiterated Rating ,Hc Wainwright ,